Stories about research and scientific development at Mount Sinai
Health Hackathon Finds Technology-Based Solutions
Mount Sinai hosted its third annual Health Hackathon, an exciting health care innovation competition that ran from Friday, October 19, through Sunday, October 21. Participants included students from the Icahn School of Medicine at Mount Sinai...
Research at the Icahn School of Medicine at Mount Sinai Included in List of Most Influential in 2018
Two publications from researchers at the Icahn School of Medicine at Mount Sinai have been included in an annual listing of the most influential research publications. The two publications were included in the annual Altmetric Top 100, which...
$43 Million Grant for Study of Environmental Effects on Children’s Health
Researchers at the Icahn School of Medicine at Mount Sinai have been awarded a $43 million grant from the National Institutes of Health (NIH) to continue their work in a sweeping five-year research program called Environmental influences on...
National Cancer Institute Leader Visits Mount Sinai
Aging is one of the greatest risk factors for developing cancer, which is most frequently diagnosed among people aged 65-74. But there are no simple explanations for the “multifaceted” science behind this connection, according to Norman E. Sharpless, MD,...
“New Heights” of Achievement Marked at Convocation
A sense of accomplishment pervaded the 2018 Convocation Ceremony, which honored 13 renowned faculty members and celebrated the 50th anniversary of the Icahn School of Medicine at Mount Sinai. The event, held on Thursday, October 4, marked the...
Advancing Research for Alzheimer’s Disease
Two physician-scientists at the Icahn School of Medicine at Mount Sinai have each received a 2019 Alzheimer’s Association Research Grant of approximately $150,000 over the next three years for their respective research projects. Ana C. Pereira,...
Reprogramming Retina Cells to Restore Vision
A team of researchers, led by Bo Chen, PhD, Associate Professor of Ophthalmology, Icahn School of Medicine at Mount Sinai, has reversed congenital blindness in mice by changing the supportive Müller glia cells in the retina into functional rod...
Lab Discovery Leads to a Remedy
A drug that recently received approval from the U.S. Food and Drug Administration (FDA) for the treatment of pain associated with the gynecological disorder endometriosis had its genesis two decades ago in the laboratory of Stuart Sealfon, MD,...
Mount Sinai Researcher Wins Young Investigator Award
Immunotherapy has been a game changer in treating some cancers, but it does not work for every patient. Building mathematical models that might predict a patient’s response is central to the work of Benjamin D. Greenbaum, PhD, Assistant Professor of...